Danicopan PMS in Korea — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Danicopan PMS in Korea — Stella

Home/Paroxysmal Nocturnal Hemoglobinuria/

View on ClinicalTrials.gov

Recruiting

Back to Paroxysmal Nocturnal Hemoglobinuria trials

Trial locations(4 sites)

South Korea

Research Site, Busan

Research Site, Daegu

Research Site, Hwasun-gun

Research Site, Seoul

Key details

Sponsor

AstraZeneca

Enrollment target

~8 participants

Started

April 2026

Primary completion

June 2028

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.